Paracrine interactions in bone-secreted products of osteoblasts permit osteoclasts to respond to parathyroid hormone
- PMID: 6323452
Paracrine interactions in bone-secreted products of osteoblasts permit osteoclasts to respond to parathyroid hormone
Abstract
During bone remodeling, activation of resorption is followed by a cycle of formation and this ordered sequence of events has long suggested that local interactions between osteoclasts and osteoblasts are an important regulatory mechanism in bone metabolism. To study this phenomenon, we have prepared bone cells containing primarily osteoclasts by brief digestion of mice calvariae in collagenase, overnight attachment to polystyrene tissue culture flasks in serumless medium supplemented with OB (osteoblast) cell conditioned medium and subsequent growth in low serum. These OC (osteoclast) cells were found to be highly enriched in acid phosphatase activity and expressed cAMP responses to PTH (parathyroid hormone) and prostaglandin E2 but exhibited no PTH-stimulated hyaluronate synthesis in contrast to prostaglandin E2. PTH effects on hyaluronate, however, could be restored upon coculture of OC cells with OB cells (noncontact) or with OB cell conditioned medium, thereby suggesting that OB cells regulate OC cell PTH responsiveness and/or differentiation by soluble cell products secreted into the medium.
Similar articles
-
Enhancement by conditioned medium of stretched calvarial bone cells of the osteoclast-like cell formation induced by parathyroid hormone in mouse bone marrow cultures.Arch Oral Biol. 1997 Mar;42(3):205-11. doi: 10.1016/S0003-9969(97)00001-0. Arch Oral Biol. 1997. PMID: 9188990
-
Differential sensitivity of osteoclasts and osteoblasts suggests that prostaglandin E1 effects on bone may be mediated primarily through the osteoclasts.Arch Biochem Biophys. 1983 Jul 1;224(1):29-35. doi: 10.1016/0003-9861(83)90187-x. Arch Biochem Biophys. 1983. PMID: 6307150
-
The effects of calcitonin, parathyroid hormone and prostaglandin E2 on cyclic AMP levels of isolated osteoclasts.Comp Biochem Physiol A Comp Physiol. 1985;81(3):653-7. doi: 10.1016/0300-9629(85)91043-6. Comp Biochem Physiol A Comp Physiol. 1985. PMID: 2863055
-
Are osteoblastic cells required for the control of osteoclast activity by parathyroid hormone?Bone Miner. 1986 Sep;1(4):261-6. Bone Miner. 1986. PMID: 2849485 Review.
-
Morphology and biochemistry of bone remodeling: possible control by vitamin D, parathyroid hormone, and other substances.Lab Invest. 1988 Oct;59(4):418-42. Lab Invest. 1988. PMID: 3050272 Review.
Cited by
-
Parathyroid hormone stimulates proliferation of chondroprogenitor cells in vitro.Calcif Tissue Int. 1986 Mar;38(3):155-62. doi: 10.1007/BF02556875. Calcif Tissue Int. 1986. PMID: 3085893
-
Localization of CD44, the hyaluronate receptor, on the plasma membrane of osteocytes and osteoclasts in rat tibiae.Cell Tissue Res. 1995 May;280(2):225-33. doi: 10.1007/BF00307793. Cell Tissue Res. 1995. PMID: 7540113
-
Increase of vertebral density by combination therapy with pulsatile 1-38hPTH and sequential addition of calcitonin nasal spray in osteoporotic patients.Calcif Tissue Int. 1989 Mar;44(3):176-80. doi: 10.1007/BF02556561. Calcif Tissue Int. 1989. PMID: 2493323
-
Surface modification of implants in long bone.Biomatter. 2012 Jul-Sep;2(3):149-57. doi: 10.4161/biom.21563. Biomatter. 2012. PMID: 23507866 Free PMC article. Review.
-
Development of monoclonal antibodies to parathyroid hormone-induced resorptive factors from osteoblast-like cells.Calcif Tissue Int. 1992 Mar;50(3):237-44. doi: 10.1007/BF00296288. Calcif Tissue Int. 1992. PMID: 1617498
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous